Skip to main content

ICU MEDICAL INC

corporate_fare Company Profile

ICU MEDICAL INC

ICUI·NASDAQ·Industrial Applications And Services·CIK 0000883984

ICU Medical, Inc. develops, manufactures, and sells medical products for infusion therapy, vascular access, and vital care applications. The company's product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions offered through a joint venture; closed system transfer devices and pharmacy compounding systems; and respiratory, anesthesia, patient monitoring, and temperature management products. Headquartered in San Clemente, California, ICU Medical was founded in 1984. Its primary customers are acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. The company has expanded through organic growth and acquisitions. In February 2017, ICU Medical acquired Pfizer Inc.'s Hospira Infusion Systems (HIS) business, which expanded its product portfolio to include a complete intravenous infusion therapy product-line from IV solutions to IV pumps to non-dedicated infusion sets. In November 2019, it acquired Pursuit Vascular, Inc., a medical device company focused on catheter disinfecting products, with its primary product being the ClearGuard ® HD cap for hemodialysis catheter maintenance. In January 2022, ICU Medical acquired Smiths Medical 2020 Limited, the global medical device business of Smiths Group plc, which added syringe and ambulatory infusion devices, vascular access, and vital care products.

ICU MEDICAL INC (NASDAQ:ICUI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors ICUI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Stockholders Approve Enhanced Governance: Simple Majority Voting & 25% Special Meeting Right
  • ICU Medical Confirms Q1 Profitability and Margin Gains, Discloses New FDA Warning Letter for Infusion Pumps
  • ICU Medical Swings to Profit in Q1 2026 with $30.1M Net Income, Improved Margins
  • ICU Medical Finalizes Annual Meeting Agenda, Proposes Simple Majority Voting and 25% Shareholder Special Meeting Right
  • ICU Medical Proposes Enhanced Shareholder Rights, Details Executive Pay Amidst Mixed 2025 Performance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.23B
Net Income
$732K
Diluted EPS
$0.03
Op. Cash Flow
$179.85M
Free Cash Flow
$91.8M
Gross Profit
$822.04M
Operating Income
$42.83M
Cash & Equivalents
$307.96M
Total Debt
$1.28B
Debt / Equity
0.60×
Net Margin
0.0%
Shares Outstanding
24.69M sh
Source: 10-K · filed 2026-02-19 · accession 0000883984-26-000008
Browse all tickers starting with I →
$142.2
52-week range · as of 2026-05-18 $107 – $160.29
Market cap
$3.55B
Volume
265.5K (0.9× avg)
3-mo avg 299.6K
Live data · 2026-06-14 03:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ICUI - Latest Insights

ICUI
May 18, 2026, 12:35 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $120.89
Real-time Price: $142.20 info
Change: +$21.31 (+18%) info
Market Cap: $3.554B info
ICUI
May 07, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $123.07
Real-time Price: $142.20 info
Change: +$19.13 (+16%) info
Market Cap: $3.554B info
ICUI
May 07, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $123.07
Real-time Price: $142.20 info
Change: +$19.13 (+16%) info
Market Cap: $3.554B info
ICUI
Apr 02, 2026, 4:07 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $123.31
Real-time Price: $142.20 info
Change: +$18.89 (+15%) info
Market Cap: $3.554B info
ICUI
Mar 23, 2026, 4:50 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $129.93
Real-time Price: $142.20 info
Change: +$12.27 (+9%) info
Market Cap: $3.554B info
ICUI
Feb 19, 2026, 4:40 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $149.74
Real-time Price: $142.20 info
Change: -$7.54 (-5%) info
Market Cap: $3.554B info
ICUI
Feb 19, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $149.74
Real-time Price: $142.20 info
Change: -$7.54 (-5%) info
Market Cap: $3.554B info